Retirement plan litigation top of mind for plan sponsors
Published Updated
4 Min Read
More From Employee Benefit News
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
How Lendmark’s CHRO is getting ahead of diabetes
Kelley Daviss brought in Twin Health and heard great things from employees — then an unexpected diagnosis led her to experience the metabolic health platform's impact herself.
How outdated data can run afoul of ERISA
A pensions specialist explains why fiduciary responsibility extends beyond investment oversight and how proper safeguards serve as a critical layer of protection.
What to know about GLP-1 demand, expense and alternatives
Multiple experts weigh in on the challenges and considerations benefit leaders need to keep in mind as they make decisions about medication coverage.
How employers can help women avoid the ‘daughter tax’
Women take on the majority of caregiving responsibilities for aging parents, often putting their financial futures at risk.
